News

    MSc thesis at Red Glead Discovery/Lund University provided new insights for the treatment of drug-resistant malaria

    Oct 24, 2022

    Evaluation of gold-based compounds as Plasmodium falciparum aquaglyceroporin inhibitors An extensive cross-disciplinary study involving computational chemistry, synthesis and in vitro testing returned promising insights on the application of metal complexes for the treatment of drug-resistant malaria. During the investigation,...

    Read More

    Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement

    Aug 30, 2022

      Lund, Sweden August 30th, 2022   Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement.   Red Glead Discovery has now...

    Read More

    Desupervised and Red Glead Discovery receive Eurostars R&D grant to deliver AId- a novel artificial intelligence-based tool for Drug Discovery

    Feb 22, 2022

    Copenhagen, Denmark and Lund, Sweden February 22nd, 2022   In this unique strategic partnership, Desupervised and Red Glead Discovery join forces to create robust AI-based solutions enabling companies to reduce cost and time in small molecule drug research and...

    Read More

    Head of Science appointed Adjunct Professor in Organic Chemistry with a green focus

    Dec 17, 2021

    Our co-worker Johan Wennerberg has been appointed Adjunct Professor in Organic Chemistry with a focus on green process development at The Faculty of Engineering, LTH, Lund University. In his new role, Johan will contribute to more interactions between academia...

    Read More

    Red Glead Discovery appoints new CFO

    Dec 10, 2021

    Red Glead Discovery AB have appointed Ann Helen Forsling as CFO to strengthen the capacity of its executive management team. Forsling have previously worked at BLS industries as a CFO for the last three years and prior to that...

    Read More

    Gazelle 2021, for the fourth time in five years!

    Nov 17, 2021

    Red Glead Discovery has been recognized as a Gazelle 2021 for the fourth time in five years! Less than 1% of Swedish companies qualify for this “fast-growth-award”. Another great recognition for the fantastic work performed by our engaged co-workers.

    Read More

    Life Science Sweden interviews CEO of RGD

    Oct 6, 2021

    Interview with Johan Evenäs, CEO of Red Glead Discovery, in Swedens leading Life Science magazine:   https://www.lifesciencesweden.se/article/view/810694/red_gleads_vd_vi_var_inga_typiska_entreprenorer_nu_vill_de_vaxa?token=7p8svttcr7zmh6ri8pe78ct4r5hlc5ij

    Read More

    Red Glead Discovery celebrates its 10-year anniversary

    Sep 21, 2021

    10-year celebrating Red Glead Discovery expects 30% higher turnover for 2021 reflecting increasing customer demand for integrated drug discovery services. Privately held Life Science consultancy company Red Glead Discovery celebrates its 10-year anniversary this month. This important milestone could...

    Read More

    RGD hosted a Peptide Symposium

    Sep 15, 2021

    For the third time, experts within the field of peptides in the Öresund region as well as the surrounding Nordic countries were gathering in Lund to present and discuss their current research. Peptides represent a unique niche for developing...

    Read More

    ApoGlyx, a company co-founded by RGD wins prestigious NLSInvest Rising Star Award 2021

    Aug 18, 2021

    ApoGlyx, a company co-founded by RGD wins prestigious NLSInvest Rising Star Award 2021. Featured in Nordic Life Science News. https://nordiclifescience.org/interview-the-winners-of-the-nlsinvest-rising-star-award/

    Read More